ABSTRACT Purpose The incidence of Extended Spectrum β–Lactamase (ESBL) producing
strains among clinical Klebsiella species and Escherichia coli isolates has been steadily …

Extended-spectrum β-lactamases (ESBLs) continue to be a major problem in clinical setups
the world over, conferring resistance to the expanded-spectrum cephalosporins. Knowledge …

Klebsiella pneumoniae and Escherichia coli are important clinical pathogens because they
are resistant to third generation cephalosporins, by having an extended-spectrum β …

The prevalence of extended-spectrum β-lactamases (ESBL)-producing organisms in an
urban hospital in Dhaka City was assessed over a 10-month period. A double disk test was …

Background: There are sporadic reports on detection of extended-spectrum beta-lactamases
(ESBL) producers from Karnataka; hence, this is a first multicentric study across Karnataka …

Extended-spectrum β-lactamases (ESBLs) produced by Klebsiella pneumoniae, Escherichia
coli, Proteus mirabilis and other enteric gram-negative bacteria have emerged because of …

Extended spectrum beta-lactmase (ESBL) producing organisms create a major problem for
clinical therapeutics. The frequency of ESBL producing strains among clinical isolates has …

Study of Extended spectrum beta-lactamases (ESBLs) producing Klebsiella species in various
clinical specimens: A preliminary re Page 1 Introduction Klebsiella species, the member of …

Extended-spectrum β-lactamases (ESBLs) continue to be a major problem in clinical setups
the world over, conferring resistance to the expanded-spectrum cephalosporins. Knowledge …

Background and Objectives. Extended spectrum β‐lactamase (ESBL) production is
increasing all over the world, and organisms other than E. coli and K. pneumoniae are …